NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
NEOGENOMICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$16.42−0.23 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $2.15B
- P/E (TTM)
- –
- Dividend yield
- –
NEOGENOMICS INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $201.66M | $186.67M | $190.17M | $187.80M | $181.33M | $168.04M | $172.00M | $167.82M | $164.50M | $156.24M | – | – | 100.0% | +11.2% |
| Clinical Services | – | – | – | – | – | – | – | $145.78M | $141.39M | $134.54M | $130.06M | $127.55M | – | – |
| Advanced Diagnostics | – | – | – | – | – | – | – | $22.04M | $23.11M | $21.71M | $25.49M | $24.40M | – | – |
| Advanced Diagnostics | – | – | – | – | – | – | – | – | – | $21.71M | – | – | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Client direct billing | $137.96M | $131.61M | $133.36M | $132.29M | $131.16M | $122.04M | $123.30M | $121.65M | $118.31M | $112.19M | – | – | 68.4% | +5.2% |
| Commercial insurance | $36.27M | $30.94M | $31.42M | $32.47M | $28.77M | $24.86M | $26.73M | $24.67M | $24.84M | $23.60M | – | – | 18.0% | +26.1% |
| Medicare and other government | $27.43M | $24.15M | $25.40M | $22.97M | $21.39M | $21.10M | $21.74M | $21.29M | $21.20M | $20.37M | – | – | 13.6% | +28.2% |
| Self-pay | $0 | -$17.00K | – | $69.00K | $20.00K | $39.00K | $227.00K | $218.00K | $157.00K | $79.00K | – | – | 0.0% | -100.0% |
By region
From the segment and revenue-disaggregation notes of Neogenomics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.